MRK vs NOW: Which Is the Better Buy?

Side-by-side comparison of Merck & Co., Inc. and ServiceNow, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-18.
Merck & Co., Inc. Β· Healthcare
$147.17
-4.1% upside to fair value
Med Conviction Grade C
VS
ServiceNow, Inc. Β· Technology
$139.82
+16.2% upside to fair value
Med Conviction Grade A- High Quality
QuantHub Verdict
NOW has more upside to fair value (+16.2%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MRK NOW
Current Price $147.17 $139.82
Fair Value Estimate $141.07 $162.50
Upside to Fair Value -4.1% +16.2%
Market Cap $363.5B $144.6B
Forward P/E β€” β€”
EV / EBITDA 29.6x 43.1x
Price / Sales 5.5x 9.8x
Price / FCF 22.6x 31.5x
Revenue Growth YoY +5.1% +24.0%
Gross Margin 75.4% 74.8%
Operating Margin 16.7% 11.4%
Return on Equity 6.6% 13.8%
Dividend Yield 2.31% 0%
FCF Yield 4.42% 3.17%
Analyst Consensus Buy Strong Buy
Investment Thesis
MRK β€” Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
NOW β€” ServiceNow, Inc.
ServiceNow provides a cloud-based enterprise workflow platform spanning IT service management, operations, employee workflows, CRM, AI orchestration and security. Business quality is high because its common data model, deeply embedded workflows and cross-department deployments create meaningful switching costs, while roughly 90% of the Fortune 500 use the platform and more than 85 billion workflo…
Accumulation Zones
Metric MRK NOW
Zone Low $105.80 $121.88
Zone High $119.91 $138.12
In Buy Zone? No No
← MRK Research    NOW Research β†’    All Research